Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
No clinical practice change indicated; leaves open Ca2+-calmodulin as a mechanistic target in epilepsy.
Robert J. DeLorenzo (1984) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: